Brady Cancer Research Institute is categorized under Research Institute in Philadelphia, PA and active since 1992.
Brady Cancer Research Institute was established in 1992, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research Institute business, which does work in the B2B market, and is classified as a Research Institute, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Luther W Brady at the company’s single location by writing to 230 North Broad St, Philadelphia, Pennsylvania PA 19102 or by phoning (215) 762-4453. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Brady Cancer Research Institute |
| Contact Person: | Luther W Brady |
| Address: | 230 North Broad St, Philadelphia, Pennsylvania 19102 |
| Phone Number: | (215) 762-4453 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1992 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research Institute |
| SIC Code: | 8733 |
| NAICS Code: | 541712 |
| Share This Business: |
Brady Cancer Research Institute was started in 1992 to provide professional Research Institute under the SIC code 8733 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Luther W Brady for inquiries that concern Brady Cancer Research Institute by calling the company number (215) 762-4453, as your correspondence is most welcome. Additionally, the physical location of the single location of Brady Cancer Research Institute can be found at the coordinates 39.957158,-75.162746 as well as the street address 230 North Broad St in Philadelphia, Pennsylvania 19102.
For its online presence, you may visit Brady Cancer Research Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.